Sai Life Sciences Gets 'Buy' Rating As PL Capital Initiates Coverage; Check Target Price

Sai Life is well placed to benefit from the shift toward outsourcing in small molecules, given its integrated capabilities across discovery, development and manufacturing and strong process chemistry expertise, believes the brokerage.
Read the full story on NDTV Profit Opens ndtvprofit.com in a new tab
Advertisement
Tech RajeshwarNeed a new website?Websites & apps built for your business — contact Tech RajeshwarContact us
This is a short summary of a story published by NDTV Profit, shown with a link to the original. The full story, photo and reporting belong to NDTV Profit.












